What itâs like to be the son of Australiaâs richest woman
After a decade of legal fights with his mother, John Hancock is making his own way in the world. And so far the returns are good. The Rich List issue is out on Friday, May 28.
John Hancock: âFor the first time in my life I had the ability to look after my family and also make decisions on investments.âÂ
May 25, 2021 â 12.04am
Save
Share
It was December 2020, John Hancock and his family were checking into a hotel just outside of Dubai, and they were drawing attention. Not because anyone recognised him as the eldest child and only son of Australiaâs richest person, Gina Rinehart. The problem was their luggage: along with suitcases, the Hancocks were hauling several pairs of snow skis.
Share this article
Share this article
FORT LEE, N.J., May 14, 2021 /PRNewswire/ Creatd, Inc. (Nasdaq CM: CRTD) ( Creatd or the Company ), is pleased to announce that it has closed a private placement of convertible notes and warrants, led by Lind Global Macro Fund, L.P., an institutional investment fund managed by The Lind Partners, LLC, (together, Lind ), for aggregate gross proceeds of $4.0 million. The financing also included two additional investors, both of whom exercised their right to participate, pursuant to the Company s December 2020 Preferred Series E offering. The notes are convertible into shares of Creatd s common stock at a price of $5.00 per share. The notes carry an original issue discount, making the aggregate principal amount $4.67 million. Additionally, the Company issued the investors an aggregate of 1,090,908 warrants, exercisable at a price of $4.50 per share. The Benchmark Company acted as exclusive Placement Agent for the financing.
Helix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 million
RICHMOND HILL, ON / ACCESSWIRE / May 11, 2021 / Helix BioPharma Corp.(TSX:HBP)( Helix or the Company ), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered into a definitive convertible security funding agreement (the Agreement ) with Lind Global Macro Fund, LP, a New York based institutional investment fund managed by The Lind Partners, LLC (together, Lind ). Under the terms of the Agreement, an initial CAD$3.5 million will be funded pursuant to the issuance of a convertible security (a Convertible Security ) which is expected to occur on or around May 12, 2021 ( First Tranche ). The Agreement also contemplates the issuance of a second Convertible Security upon the mutual agreement of the Company and Lind for gross proceeds to the Company of up to CAD$6.5 million (the Second Tranche ).
Provided by PR Newswire
NioCorp Announces Closing of Up-Sized Private Placement for Gross Proceeds of C$6.2 Million
NioCorp Announces Closing of Up-Sized Private Placement for Gross Proceeds of C$6.2 Million
Offering Was Set at a Premium to the Share Price When Launched
PR Newswire
CENTENNIAL, Colo., May 11, 2021
CENTENNIAL, Colo., May 11, 2021 /PRNewswire/ NioCorp Developments Ltd. ( NioCorp or the Company ) (TSX:NB) (OTCQX:NIOBF) is pleased to announce that it has closed its previously announced non-brokered private placement (the Private Placement ) of units (the Units ) of the Company. A total up-sized offering of 4,334,157 Units were issued at a price per Unit of C$1.43, for total gross proceeds to the Company of approximately C$6.2 million.
Advertisement
Edenville Energy Plc, an AIM quoted company operating the Rukwa Coal Project in southwest Tanzania, has announced a number of developments.
Highlights
Proposed strategic investment by Anthony (Tony) Buckingham of £1 million as part of a £2.48 million (before expenses) placing, which includes participation from the company’s substantial shareholders of, in aggregate, an additional £1.05 million.
Additional assets targeted in line with previous announcements.
Strategic investor
The company is pleased to announce that Buckingham has agreed a £1 million strategic investment in the company through the placing (as defined below), giving him a shareholding of 18.5% of the company’s issued share capital, as enlarged by the placing, which is subject to, inter alia, shareholder approval at a General Meeting to be convened shortly.